Barostim therapy for heart failure with reduced pumping ability
Part of Heart & circulation clinical trials.
This trial tests a device called Barostim NEO that is implanted in the neck to help treat heart failure. It may improve symptoms by stimulating nerves that help the heart work better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart failure with symptoms like shortness of breath or fatigue during daily activities (NYHA class III).
- Your heart's pumping ability is 35% or less (as measured by an ejection fraction test).
- You are already taking the best medications for heart failure.
- You have had the Barostim NEO device implanted within the last 30 days.
- You have signed a consent form approved by an ethics committee.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a lab-made heart tissue (“engineered myocardium”) placed surgically to help the heart work better in people with advanced heart failure. It mainly checks safety first, and also looks for signs the patch can improve heart function in selected patients.
This trial tests a device called Barostim, which is implanted under the skin to stimulate nerves that help control heart failure. It's for people with mild to moderate heart failure whose symptoms are not fully controlled by medications.
This trial tests a device that treats and monitors heart failure. It may help people with chronic heart failure and reduced heart function who still have symptoms despite standard treatments.
This trial tests a non-invasive device that sends gentle electrical pulses to a nerve in your ear (vagus nerve) to see if it improves heart function in people with chronic heart failure. If you have heart failure with a reduced pumping ability, you may be able to join.
This trial tests a new treatment that uses a device to calm overactive nerves in the lung's blood vessels. It is for heart failure patients who also have high blood pressure in their lungs, to see if it can help them breathe easier and feel better.
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.